Default: Breast Cancer Research

ISSN: 1465-5411

Journal Home

Journal Guideline

Breast Cancer Research Q1 Unclaimed

BioMed Central Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Breast Cancer Research is a journal indexed in SJR in Oncology and Cancer Research with an H index of 175. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2890 €. The scope of the journal is focused on oncology, breast cancer. It has an SJR impact factor of 2,578 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,578.

Breast Cancer Research focuses its scope in these topics and keywords: breast, cancer, tumor, estrogen, metastasis, receptor, deficiency, current, confer, community, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -


2890 €

Inmediate OA


Embargoed OA

- €

Non OA


Breast Cancer Research


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

breast, cancer, tumor, estrogen, metastasis, receptor, deficiency, current, confer, community, eepd, endonuclease, endothelial, endothelium, evidence, extracellular, favorable, gper, collageni, clinical, claudinlow, anoikisresistant, antagonist, approval, augments, basallike, characterization, cancerthe, cd, cellsinvasive, cellsneutrophil, cellsnitric, characterizing, oncology, breast cancer

Best articles by citations

Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters

View more

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

View more

P8-03: Exact quantification of gene amplification in archival tissue sections by laser-assisted microdissection and real-time PCR

View more

N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma

View more

Combining the strength of genomics, nanoparticle technology, and direct intraductal delivery for breast cancer treatment

View more

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor beta1 signaling in metastatic breast cancers

View more

Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling

View more

Retinoblastoma tumor suppressor pathway in breast cancer: prognosis, precision medicine, and therapeutic interventions

View more

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

View more

Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation

View more

Trastuzumab emtansine: mechanisms of action and drug resistance

View more

Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice

View more

Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells

View more

Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening

View more

Outsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response

View more

Mammographic texture resemblance generalizes as an independent risk factor for breast cancer

View more

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue

View more

Phase 2 trial of everolimus and carboplatin combination in patients with triple negative metastatic breast cancer

View more

Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects

View more

Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study

View more

Are triple negative tumours and basal-like breast cancer synonymous?

View more

Effects of an exercise and hypocaloric healthy eating intervention on indices of psychological health status, hypothalamic-pituitary-adrenal axis regulation and immune function after early-stage breast cancer: a randomised controlled trial

View more

Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis

View more

Breast tumors from CHEK2 1100delC mutation carriers: genomic landscape and clinical implications

View more